Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jan;39(1):70-79.
doi: 10.1016/j.it.2017.08.003. Epub 2017 Aug 31.

From Original Antigenic Sin to the Universal Influenza Virus Vaccine

Affiliations
Review

From Original Antigenic Sin to the Universal Influenza Virus Vaccine

Carole Henry et al. Trends Immunol. 2018 Jan.

Abstract

Antibody responses are essential for protection against influenza virus infection. Humans are exposed to a multitude of influenza viruses throughout their lifetime and it is clear that immune history influences the magnitude and quality of the antibody response. The 'original antigenic sin' concept refers to the impact of the first influenza virus variant encounter on lifelong immunity. Although this model has been challenged since its discovery, past exposure, and likely one's first exposure, clearly affects the epitopes targeted in subsequent responses. Understanding how previous exposure to influenza virus shapes antibody responses to vaccination and infection is critical, especially with the prospect of future pandemics and for the effective development of a universal influenza vaccine.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Antibody responses to influenza virus and antigenic seniority
A. Primary exposure to an influenza virus (early in childhood) induces activation of influenza virus-reactive naive B cells. After antigen encounter and T cell help, naïve B cells enter a germinal center (GC) reaction where they class-switch and affinity mature by somatic hypermutation. The majority of the B cells will recognize epitopes on the immunodominant head domain of HA (in orange) but a few might recognize the more conserved stalk region (in blue). After 7–10 days, influenza-reactive short-lived antibody secreting cells (ASCs) or plasmablasts are present in circulation and secrete antibodies. The generation of influenzareactive memory B cells and long-lived plasma cells also occur from the GC and reflects the B cells that have been activated, with the majority of the antibody specificity being directed towards the HA head domain. B. During secondary exposure to influenza virus/vaccine, memory B cells generated from the first exposure will be reactivated. However different outcomes will happen if the second exposure (infection or vaccination) is a seasonal influenza virus strain or a pandemic strain. In the case of a seasonal virus, antigenic drift happens from year to year resulting in small changes in the globular head. The pool of memory B cells generated from previous exposure will recognize these drifted epitopes on the head, cells will be reactivated and some of them will adapt in the GC by somatic hypermutation to increase binding to the drifted epitope (in red). Short-lived ASCs, long-lived plasma cells and memory B cells will be generated and the antibody specificity will be a mixture of the senior strain and the more junior strain epitopes (antigenic imprinting) but mainly targeting the head. Thus, previously encountered strains will be boosted by encounter with strains of the same subtype and over time, these responses accumulate. The less frequent memory B cells targeting conserved epitopes will not be boosted and will be diluted out. In the OAS model, the reduction in access to antigen because of pre-existing cross-reactive antibodies (epitope masking) is what would favor recall of memory over de novo activation of naïve B cells. In the case of a pandemic influenza virus (shifted), the majority of the epitopes on the head domain are new (in purple) whereas conserved epitopes on the HA stalk remain the same. Cross-reactive memory B cells specific to the HA stalk (in blue) are being re-activated and now the product of the GC reaction is an antibody response targeting mainly the stalk domain of HA. Naïve responses to the novel epitopes on the head domain are also induced but most likely participate at a lower significance to the overall response.
Figure 2
Figure 2. Strategies to boost broadly neutralizing stalk antibodies
The first strategy focuses on headless HAs, with the removal of the entire head domain to make the stalk domain more “available” and thus induce antibody responses against the stalk domain. The second strategy uses chimeric HAs consisting of the stalk domain from H1, H3 or influenza B viruses (here H1N1 as an example) in combination with head domains of exotic influenza virus strains (avian strains for the majority). Sequential exposure with such chimeric HAs elicits boosted responses against the conserved stalk domain. Structures are based on PDB ID 4M4Y and visualized using PyMOL.

References

    1. Gerdil C. The annual production cycle for influenza vaccine. Vaccine. 2003;21(16):1776–9. - PubMed
    1. Air GM. Sequence relationships among the hemagglutinin genes of 12 subtypes of influenza A virus. Proc Natl Acad Sci U S A. 1981;78(12):7639–43. - PMC - PubMed
    1. Tong S, et al. New world bats harbor diverse influenza A viruses. PLoS Pathog. 2013;9(10):e1003657. - PMC - PubMed
    1. Zhu X, et al. Hemagglutinin homologue from H17N10 bat influenza virus exhibits divergent receptor-binding and pH-dependent fusion activities. Proc Natl Acad Sci U S A. 2013;110(4):1458–63. - PMC - PubMed
    1. Rota PA, et al. Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. Virology. 1990;175(1):59–68. - PubMed

Publication types